Pulmonary arterial hypertension Trials in Toledo, Spain
Conditions / Pulmonary arterial hypertension / Toledo, Spain
Clinical trials for Pulmonary arterial hypertension investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05557942 | Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) | TERMINATED | PHASE3 |
| NCT06664801 | A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024) | COMPLETED | PHASE2 |
| NCT05036135 | A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) | TERMINATED | PHASE2/PHASE3 |
| NCT02891850 | Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy | COMPLETED | PHASE4 |
| NCT02725372 | Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH | TERMINATED | PHASE3 |
| NCT05147805 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension | COMPLETED | PHASE2 |
| NCT04796337 | A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05934526 | Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) | COMPLETED | — |
| NCT04811092 | Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) | TERMINATED | — |
| NCT06274801 | Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | ACTIVE_NOT_RECRUITING | — |